Potassium clavulanate CAS# 61177-45-5

Potassium clavulanate CAS# 61177-45-5

Product Overview:
Potassium Clavulanate, also known as CLAVULANIC ACID POTASSIUM SALT with the CAS#61177-45-5, is a potent β-lactamase inhibitor that is revolutionizing the way we combat bacterial infections in the industrial pharmaceutical sector. As a key component in the synthesis of advanced antibiotics, our Cellulose Clavulanate is designed to meet the rigorous demands of modern manufacturing processes.

Market Relevance:
In the competitive landscape of the pharmaceutical industry, the need for effective antibacterial agents is paramount. Potassium Clavulanate plays a crucial role in this domain by enhancing the potency of β-lactam antibiotics, thus addressing the growing issue of antibiotic resistance. Our product is crafted to ensure compatibility with a wide range of manufacturing protocols, providing a versatile solution for your production needs.

Key Features:
Enhanced Antibacterial Synergy: By inhibiting β-lactamase enzymes produced by bacteria, Potassium Clavulanate extends the lifespan and effectiveness of β-lactam antibiotics, ensuring they remain a viable treatment option in the face of evolving bacterial resistance.

High Purity and Compliance: Our CLAVULANIC ACID POTASSIUM SALT is manufactured to the highest purity standards, ensuring consistency and reliability in your pharmaceutical formulations. With a unique identifier of CAS#61177-45-5, our product adheres to international regulatory requirements, facilitating seamless integration into your supply chain.

Versatile Applications: Potassium Clavulanate is not limited to a single application; it is used in various pharmaceutical formulations, including combination drugs with amoxicillin, to treat a broad spectrum of bacterial infections.

Application in Industries:
Pharmaceutical Manufacturing: Our Potassium Clavulanate is an essential ingredient in the production of antibiotics, where it is combined with other active pharmaceutical ingredients to create synergistic effects that enhance treatment outcomes.

Research and Development: In the R&D sector, our Cellulose Clavulanate is used in the development of new antibacterial drugs, providing a foundation for innovation in the fight against antibiotic resistance.

Conclusion:
Our Potassium Clavulanate, identified by the CAS#61177-45-5, is more than just a β-lactamase inhibitor; it is a critical component in the arsenal against bacterial resistance. We are committed to delivering a product that meets the highest standards of the pharmaceutical industry, ensuring the efficacy and safety of your antibiotic formulations.